Granata Bio Expands Women's Health Portfolio with Acquisition of US-Based Oviva Therapeutics
Granata BioGranata Bio ("Granata") today announced the acquisition of Oviva Therapeutics, Inc. ("Oviva"), a pioneering women's health biotech company focused on advancing treatments that address female physiology, with an emphasis on ovarian aging.